CymitQuimica logo

CAS 1616392-22-3

:

GSK-3326595

Description:
GSK-3326595, with the CAS number 1616392-22-3, is a small molecule that has been investigated primarily for its potential therapeutic applications in the treatment of various diseases, particularly in the field of oncology. It functions as a selective inhibitor of specific protein targets, which can modulate cellular pathways involved in cancer progression. The compound is characterized by its unique chemical structure, which includes specific functional groups that contribute to its biological activity and selectivity. In preclinical studies, GSK-3326595 has shown promise in inhibiting tumor growth and enhancing the efficacy of other therapeutic agents. Its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are critical for determining its suitability for clinical use. As with many investigational drugs, ongoing research is essential to fully understand its safety profile, potential side effects, and optimal dosing regimens. Overall, GSK-3326595 represents a significant area of interest in drug development aimed at improving cancer treatment outcomes.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.